Prostate-specific antigen may serve as a pathological predictor in breast cancer

Romanian Journal of Morphology and Embryology

Volumn 49, Issue 2, 2008, Pages 173-180

  Nariţa, Diana ^a   Anghel, A ^a   Motoc, Marilena ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Breast cancer; HER2 neu; Prostate specific antigen; Steroid hormone receptors

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ARTICLE; BREAST TUMOR; CANCER STAGING; FEMALE; HUMAN; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 52749097910     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. AMERICAN CANCER SOCIETY INC., Breast Cancer Facts & Figures 2005-2006, Atlanta, 2005.
2. PARTIN A. W., OESTERLING J. E., The clinical usefulness of prostate specific antigen: update 1994, J Urol, 1994, 152(5 Pt 1):1358-1368.
3. PAPOTTI M., PATIES C., PEVERI V., MOSCUZZA L., BUSSOLATI G., Immunocytochemical detection of prostate-specific antigen (PSA) in skin adnexal and breast tissues and tumors, Basic Appl Histochem, 1989, 33(1):25-29.
4. DIAMANDIS E. P., YU H., SUTHERLAND D. J., Detection of prostate-specific antigen immunoreactivity in breast tumors, Breast Cancer Res Treat, 1994, 32(3):301-310.
5. DIAMANDIS E. P., YU H., Nonprostatic sources of prostate-specific antigen, Urol Clin North Am, 1997, 24(2):275-282.
6. YU H., DIAMANDIS E. P., LEVESQUE M., GIAI M., ROAGNA R., PONZONE R., SISMONDI P., MONNE M., CROCE C. M., Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue, Breast Cancer Res Treat, 1996, 40(2):171-178.
7. MONNE M., CROCE C. M., YU H., DIAMANDIS E. P., Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors, Cancer Res, 1994, 54(24):6344-6347.
8. BLACK M. H., DIAMANDIS E. P., The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast, Breast Cancer Res Treat, 2000, 59(1):1-14.
9. SAUTER E. R., KLEIN G., WAGNER-MANN C., DIAMANDIS E. P., Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer, Cancer Detect Prev, 2004, 28(1):27-31.
10. ZARGHAMI N., GRASS L., DIAMANDIS E. P., Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer, Br J Cancer, 1997, 75(4):579-588.
11. TANAKA A., KAMIAKITO T., TAKAYASHIKI N., SAKURAI S., SAITO K., Fibroblast growth factor 8 expression in breast carcinoma: associations with androgen receptor and prostate specific antigen expressions, Virchows Arch, 2002, 441(4):380-384.
12. TAVASSOLI F. A., DEVILEE P., World Health Organization Classification of Tumors. Pathology and genetics of tumours of the breast and female genital organs, IARC Press, Lyon, 2003.
13. ELSTON C. W., ELLIS I. O., Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up, Histopathology, 1991, 19(5):403-410.
14. MOINFAR F., OKCU M., TSYBROVSKYY O., REGITNIG P., LAX S. F., WEYBORA W., RATSCHEK M., TAVASSOLI F. A., DENK H., Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies, Cancer, 2003, 98(4):703-711.
15. ELLIS I. O., DOWSETT M., BARTLETT J., WALKER R., COOKE T., GULLICK W., GUSTERSON B., MALLON E., LEE P. B., Recommendations for HER2 testing in the UK, J Clin Pathol, 2000, 53(12):890-892.
16. PEEHL D. M., COHEN P., ROSENFELD R. G., The insulin-like growth factor system in the prostate, World J Urol, 1995, 13(5):306-311.
17. IWAMURA M., HELLMAN J., COCKETT A. T. K., LILJA H., GERSHAGEN S., Alterations of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as result of limited proteolysis by prostate-specific antigen, Urology, 1996, 48(2):317-325.
18. WULF G. G., JÜRGENS B., LIERSCH T., GATZEMEIER W., RAUSCHECKER H., BUSKE C., HÜFNER M., HIDDEMANN W., WÖRMANN B., Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer, Cancer Res Clin Oncol, 1997, 123(9):514-521.
19. FORTIER A. H., NELSON B. J., GRELLA D. K., HOLADAY J. W., Antiangiogenic activity of prostate-specific antigen, J Natl Cancer Inst, 1999, 91(19):1635-1640.
20. LAI L. C., ERBAS H., LENNARD T. W., PEASTON R. T., Prostate-specific antigen in breast cyst fluid: possible role of prostate-specific antigen in hormone-dependent breast cancer, Int J Cancer, 1996, 66(6):743-746.
21. BODEY B., BODEY B. JR., KAISER H. E., Immunocytochemical detection of prostate specific antigen expression in human breast carcinoma cells, Anticancer Res, 1997, 17(4A):2577-2581.
22. MANNELLO F., GAZZANELLI G., Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?, Breast Cancer Res, 2001, 3(4):238-243.
23. YANG Q., NAKAMURA M., NAKAMURA Y., YOSHIMURA G., SUZUMA T., UMEMURA T., TAMAKI T., MORI I., SAKURAI T., KAKUDO K., Correlation of prostate-specific antigen promoter polymorphism with clinicopathological characteristics in breast cancer, Anticancer Res, 2002, 22(3):1825-1828.
24. YU H., GIAI M., DIAMANDIS E. P., KATSAROS D., SUTHERLAND D. J., LEVESQUE M. A., ROAGNA R., PONZONE R., SISMONDI P., Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer, Cancer Res, 1995, 55(10):2104-2110.
25. FOEKENS J. A., DIAMANDIS E. P., YU H., LOOK M. P., MEIJER-VAN GELDER M. E., VAN PUTTEN W. L., KLIJN J. G., Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer, Br J Cancer, 1999, 79(5-6):888-894.
26. KIDWAI N., GONG Y., SUN X., DESHPANDE C. G., YELDANDI A. V., RAO M. S., BADVE S., Expression of androgen receptor and prostate-specific antigen in male breast carcinoma, Breast Cancer Res, 2004, 6(1):R18-R23.
27. GATALICA Z., NORRIS B. A., KOVATICH A. J., Immunohisto-chemical localization of prostate-specific antigen in ductal epithelium of male breast. Potential diagnostic pitfall in patients with gynecomastia, Appl Immunohistochem Mol Morphol, 2000, 8(2):158-161.
28. UMEKITA Y., YOSHIDA H., Immunohistochemical study of hormone receptor and hormone-regulated protein expression in phyllodes tumor: comparison with fibroadenoma, Virchows Arch, 1998, 433(4):311-314.
29. ALANEN K. A., KUOPIO T., COLLAN Y. U., KRONQVIST P., JUNTTI L., NEVALAINEN T. J., Immunohistochemical labeling for prostate-specific antigen in breast carcinomas, Breast Cancer Res Treat, 1999, 56(2):169-176.
30. HEYL W., WOLFF J. M., BIESTERFELD S., SCHRÖDER W., ZITZELSBERGER D., JAKSE G., RATH W., Immunohisto-chemical analysis of prostate-specific antigen does not correlate to other prognostic factors in breast cancer, Anticancer Res, 1999, 19(4A):2563-2565.
31. MILLER M. K.,UNGER P. D., BLEIWEISS I. J., Immunohistochemical analysis of prostate specific antigen in breast cancer, Breast Cancer Res Treat, 2001, 68(2):111-116.
32. YAO G. Y., ZHOU J. L., ZHAO Z. S., RUAN J., Biological characteristics of breast carcinomas with neuroendocrine cell differentiation, Chin Med J (Engl), 2004, 117(10):1536-1540.
33. NARIŢA D.,RAICA M., ANGHEL A., SUCIU C., CÎMPEAN A. M., Immunohistochemical localization of prostate-specific antigen in benign and malignant breast conditions, Rom J Morph Embryol, 2005, 46(1):41-45.
34. NARITA D., CIMPEAN A. M., ANGHEL A., RAICA M., Prostate-specific antigen value as a marker in breast cancer, Neoplasma, 2006, 53(2):161-167.
35. RIVA C., DAINESE E., CAPRARA G., ROCCA P. C., MASSARELLI G., TOT T., CAPELLA C., EUSEBI V., Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma, Virchows Arch, 2005, 447(4):695-700.
36. HOWARTH D. J., ARONSON I. B., DIAMANDIS E. P., Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues, Br J Cancer, 1997, 75(11):1646-1651.
37. BAYER-GARNER I. B., SMOLLER B., Androgen receptors: a marker of increase sensitivity for identifying breast cancer in skin metastasis of unknown primary site, Mod Pathol, 2000, 13(2):119-122.
38. LEAL C., HENRIQUE R., MONTEIRO P., LOPES C., BENTO M. J., DE SOUSA C. P., LOPES P., OLSON S., SILVA M. D., PAGE D. L., Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers, Hum Pathol, 2001, 32(5): 487-493.
39. GATALICA Z., Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ, Pathol Res Pract, 1997, 193(11-12):753-758.
40. SELIM A. G., EL-AYAT G., WELLS C. A., Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors, J Clin Pathol, 2002, 55(1):14-16.
41. MANNELLO F., BOCCHIOTTI G., BIANCHI G., MARCHEGGIANI F., GAZZANELLI G., Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids, Breast Cancer Res Treat, 1996, 38(3):247-252.
42. TSUNG J. S., WANG T. Y., WANG S. M., YANG P. S., Cytological and biochemical studies of breast cyst fluid, Breast, 2005, 14(1):37-41.
43. HALL R. E., CLEMENTS J. A., BIRREL S. N., TILLEY W. D., Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast, Br J Cancer, 1998, 78(3):360-365.
44. MAGKLARA A., BROWN T. J., DIAMANDIS E. P., Characterization of androgen receptor and nuclear receptor co-regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3, Int J Cancer, 2002, 100(5): 507-514.
45. ORTMANN J., PRIFTI S., BOHLMANN M. K., REHBERGER-SCHNEIDER S., STROWITZKI T., RABE T., Testosterone and 5α-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines, Gynecol Endocrinol, 2002, 16(2):113-120.
46. SOMBOONPORN W., DAVIS S. R., NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL, Testosterone effects on the breast: implications for testosterone therapy for women, Endocr Rev, 2004, 25(3):374-388.
47. BHARAJ B., SCORILAS A., DIAMANDIS E. P., GIAI M., LEVESQUE M. A., SUTHERLAND D. J., HOFFMAN B. R., Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter, Breast Cancer Res Treat, 2000, 61(2):111-119.
48. MAJUMDAR S., DIAMANDIS E. P., The promoter and the enhancer region of the prostate-specific antigen of the KLK3 (prostate specific antigen) gene is frequently mutated in breast tumors and in breast carcinoma cell lines, Br J Cancer, 1999, 79(9-10):1594-1602.
49. MITCHELL G., SIBLEY P. E., WILSON A. P., SAUTER E., A'HERN R., EELES R. A., Prostate-specific antigen in nipple aspiration fluid: menstrual cycle variability and correlation with serum prostate-specific antigen, Tumor Biol, 2002, 23(5):287-297.
50. YU H., LEVESQUE M. A., CLARK G. M., DIAMANDIS E. P., Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study, Clin Cancer Res, 1998, 4(6):1489-1497.